• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖有利于形成与心脏病风险相关的含有载脂蛋白E和C-III的高密度脂蛋白亚组分。

Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.

作者信息

Talayero Beatriz, Wang Liyun, Furtado Jeremy, Carey Vincent J, Bray George A, Sacks Frank M

机构信息

Department of Nutrition, Harvard School of Public Health, Boston, MA.

Channing Division of Network Medicine, Boston, MA.

出版信息

J Lipid Res. 2014 Oct;55(10):2167-77. doi: 10.1194/jlr.M042333. Epub 2014 Jun 25.

DOI:10.1194/jlr.M042333
PMID:24966274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4174008/
Abstract

Human HDLs have highly heterogeneous composition. Plasma concentrations of HDL with apoC-III and of apoE in HDL predict higher incidence of coronary heart disease (CHD). The concentrations of HDL-apoA-I containing apoE, apoC-III, or both and their distribution across HDL sizes are unknown. We studied 20 normal weight and 20 obese subjects matched by age, gender, and race. Plasma HDL was separated by sequential immunoaffinity chromatography (anti-apoA-I, anti-apoC-III, anti-apoE), followed by nondenaturing-gel electrophoresis. Mean HDL-cholesterol concentrations in normal weight and obese subjects were 65 and 50 mg/dl (P = 0.009), and total apoA-I concentrations were 119 and 118 mg/dl, respectively. HDL without apoE or apoC-III was the most prevalent HDL type representing 89% of apoA-I concentration in normal weight and 77% in obese (P = 0.01) individuals; HDL with apoE-only was 5% versus 8% (P = 0.1); HDL with apoC-III-only was 4% versus 10% (P = 0.009); and HDL with apoE and apoC-III was 1.5% versus 4.6% (P = 0.004). Concentrations of apoE and apoC-III in HDL were 1.5-2× higher in obese subjects (P ≤ 0.004). HDL with apoE or apoC-III occurred in all sizes among groups. Obese subjects had higher prevalence of HDL containing apoE or apoC-III, subfractions associated with CHD, whereas normal weight subjects had higher prevalence of HDL without apoE or apoC-III, subfractions with protective association against CHD.

摘要

人类高密度脂蛋白(HDL)的组成具有高度异质性。含有载脂蛋白C-III(apoC-III)的HDL的血浆浓度以及HDL中的载脂蛋白E(apoE)可预测冠心病(CHD)的更高发病率。含有apoE、apoC-III或两者的HDL-载脂蛋白A-I(apoA-I)的浓度及其在不同大小HDL中的分布情况尚不清楚。我们研究了20名体重正常和20名肥胖受试者,这些受试者在年龄、性别和种族方面相匹配。通过连续免疫亲和色谱法(抗apoA-I、抗apoC-III、抗apoE)分离血浆HDL,随后进行非变性凝胶电泳。体重正常和肥胖受试者的平均HDL胆固醇浓度分别为65和50mg/dl(P = 0.009),总apoA-I浓度分别为119和118mg/dl。不含apoE或apoC-III的HDL是最常见的HDL类型,在体重正常个体中占apoA-I浓度的89%,在肥胖个体中占77%(P = 0.01);仅含apoE的HDL分别为5%和8%(P = 0.1);仅含apoC-III的HDL分别为4%和10%(P = 0.009);同时含有apoE和apoC-III的HDL分别为1.5%和4.6%(P = 0.004)。肥胖受试者HDL中apoE和apoC-III的浓度高1.5至2倍(P≤0.004)。含有apoE或apoC-III的HDL在各组的所有大小中均有出现。肥胖受试者中含有apoE或apoC-III的HDL(与CHD相关的亚组分)的患病率较高,而体重正常受试者中不含apoE或apoC-III的HDL(对CHD有保护作用的亚组分)的患病率较高。

相似文献

1
Obesity favors apolipoprotein E- and C-III-containing high density lipoprotein subfractions associated with risk of heart disease.肥胖有利于形成与心脏病风险相关的含有载脂蛋白E和C-III的高密度脂蛋白亚组分。
J Lipid Res. 2014 Oct;55(10):2167-77. doi: 10.1194/jlr.M042333. Epub 2014 Jun 25.
2
Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.正常血脂和高甘油三酯血症受试者中载脂蛋白C-III的血浆脂蛋白分布:不同脂蛋白组分中载脂蛋白C-III与载脂蛋白E比值的比较
J Lipid Res. 1997 Jul;38(7):1421-32.
3
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.中心性肥胖男性的血浆载脂蛋白C-III转运:与极低密度脂蛋白载脂蛋白B及高密度脂蛋白载脂蛋白A-I代谢的关联
J Clin Endocrinol Metab. 2008 Feb;93(2):557-64. doi: 10.1210/jc.2006-2676. Epub 2007 Nov 13.
4
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism.人类血浆中高密度脂蛋白载脂蛋白C-I、载脂蛋白C-III和载脂蛋白E的周转率:关于高密度脂蛋白载脂蛋白C-III与载脂蛋白A-I代谢之间联系的体内证据。
J Lipid Res. 2003 Oct;44(10):1976-83. doi: 10.1194/jlr.M300209-JLR200. Epub 2003 Jul 16.
5
ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.载脂蛋白 E 和载脂蛋白 C-III 定义的高密度脂蛋白亚型:其卵磷脂胆固醇酰基转移酶和胆固醇酯转移蛋白含量和活性的描述性研究。
Lipids Health Dis. 2020 May 25;19(1):106. doi: 10.1186/s12944-020-01291-x.
6
Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.人载脂蛋白 A-II 通过调节脂蛋白脂肪酶活性和高密度脂蛋白蛋白质组来决定血浆甘油三酯。
Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):232-8. doi: 10.1161/ATVBAHA.109.198226. Epub 2009 Nov 12.
7
Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.载脂蛋白 E 与载脂蛋白 C-III 的 VLDL 和 LDL 与较低的冠心病风险相关。
J Am Heart Assoc. 2013 May 14;2(3):e000130. doi: 10.1161/JAHA.113.000130.
8
Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE.高密度脂蛋白大小范围内人血浆载脂蛋白E脂蛋白的特征:重点关注前β1-LpE、前β2-LpE和α-LpE。
J Lipid Res. 1997 Jan;38(1):35-48.
9
Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE.人血浆样本的储存会导致载脂蛋白C-III和载脂蛋白E的脂蛋白分布发生改变。
J Lipid Res. 2004 Aug;45(8):1572-9. doi: 10.1194/jlr.D300041-JLR200. Epub 2004 May 16.
10
Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.心肌梗死风险不同的两个人群中载脂蛋白B和非载脂蛋白脂蛋白中的载脂蛋白C-III和E:ECTIM研究。心肌梗死病例对照研究。
J Lipid Res. 1996 Mar;37(3):508-17.

引用本文的文献

1
Hepatic Abnormal Secretion of Apolipoprotein C3 Promotes Inflammation in Aortic Dissection.载脂蛋白C3的肝脏异常分泌促进主动脉夹层炎症。
J Am Heart Assoc. 2025 Feb 4;14(3):e037172. doi: 10.1161/JAHA.124.037172. Epub 2025 Jan 23.
2
Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia.富含甘油三酯的脂蛋白、残胆固醇以及载脂蛋白 CII、CIII 和 E 在精神分裂症患者中的水平。
J Lipid Res. 2024 Jul;65(7):100577. doi: 10.1016/j.jlr.2024.100577. Epub 2024 Jun 13.
3
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.探索载脂蛋白 C-III:病理生理学和药理学相关性。
Cardiovasc Res. 2024 Feb 17;119(18):2843-2857. doi: 10.1093/cvr/cvad177.
4
Associations between Alcohol Consumption and HDL Subspecies Defined by ApoC3, ApoE and ApoJ: the Cardiovascular Health Study.饮酒与载脂蛋白 C3、载脂蛋白 E 和载脂蛋白 J 定义的高密度脂蛋白亚类之间的关联:心血管健康研究。
Curr Probl Cardiol. 2023 Jan;48(1):101395. doi: 10.1016/j.cpcardiol.2022.101395. Epub 2022 Sep 10.
5
Pharmacological Inhibition of CETP (Cholesteryl Ester Transfer Protein) Increases HDL (High-Density Lipoprotein) That Contains ApoC3 and Other HDL Subspecies Associated With Higher Risk of Coronary Heart Disease.CETP(胆固醇酯转移蛋白)抑制剂可增加富含 ApoC3 和其他与冠心病风险增加相关的 HDL 亚类的 HDL(高密度脂蛋白)。
Arterioscler Thromb Vasc Biol. 2022 Feb;42(2):227-237. doi: 10.1161/ATVBAHA.121.317181. Epub 2021 Dec 23.
6
Changes in gut-microbiota-related metabolites and long-term improvements in lipoprotein subspecies in overweight and obese adults: the POUNDS lost trial.超重和肥胖成年人的肠道微生物群相关代谢物的变化与脂蛋白亚类的长期改善:POUNDS LOST 试验。
Int J Obes (Lond). 2021 Dec;45(12):2600-2607. doi: 10.1038/s41366-021-00939-7. Epub 2021 Aug 23.
7
HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study.载脂蛋白 C-III 的高密度脂蛋白与胰岛素敏感性相关:一项多中心队列研究。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):e2928-e2940. doi: 10.1210/clinem/dgab234.
8
Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.载脂蛋白定义的高密度脂蛋白亚类与 4 项前瞻性研究中的冠心病风险差异。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2714-2727. doi: 10.1161/ATVBAHA.120.314609. Epub 2020 Sep 10.
9
ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.载脂蛋白 E 和载脂蛋白 C-III 定义的高密度脂蛋白亚型:其卵磷脂胆固醇酰基转移酶和胆固醇酯转移蛋白含量和活性的描述性研究。
Lipids Health Dis. 2020 May 25;19(1):106. doi: 10.1186/s12944-020-01291-x.
10
The association between the rs10248618 SNP and serum lipid traits, the risk of coronary artery disease, and ischemic stroke.rs10248618单核苷酸多态性与血清脂质特征、冠状动脉疾病风险及缺血性中风之间的关联。
Int J Clin Exp Pathol. 2018 Sep 1;11(9):4585-4594. eCollection 2018.

本文引用的文献

1
Effects of extended-release niacin with laropiprant in high-risk patients.烟酸缓释剂联合拉罗匹仑在高危患者中的作用。
N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955.
2
Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.载脂蛋白 E 与载脂蛋白 C-III 的 VLDL 和 LDL 与较低的冠心病风险相关。
J Am Heart Assoc. 2013 May 14;2(3):e000130. doi: 10.1161/JAHA.113.000130.
3
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond.高密度脂蛋白的蛋白质组多样性:我们对其在脂质转运及其他方面重要性的新兴认识。
J Lipid Res. 2013 Oct;54(10):2575-85. doi: 10.1194/jlr.R035725. Epub 2013 Feb 24.
4
Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease.载脂蛋白 C-III 作为高密度脂蛋白胆固醇与冠心病事件之间关联的潜在调节剂。
J Am Heart Assoc. 2012 Apr;1(2). doi: 10.1161/JAHA.111.000232. Epub 2012 Apr 24.
5
Effects of dalcetrapib in patients with a recent acute coronary syndrome.近期急性冠脉综合征患者应用达塞曲匹的效果。
N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797. Epub 2012 Nov 5.
6
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.血浆高密度脂蛋白胆固醇与心肌梗死风险:一项孟德尔随机化研究。
Lancet. 2012 Aug 11;380(9841):572-80. doi: 10.1016/S0140-6736(12)60312-2. Epub 2012 May 17.
7
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.烟酸在接受强化他汀类药物治疗的低 HDL 胆固醇水平患者中的应用。
N Engl J Med. 2011 Dec 15;365(24):2255-67. doi: 10.1056/NEJMoa1107579. Epub 2011 Nov 15.
8
LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.LDL -apheresis 在家族性高胆固醇血症中消耗 apoE-HDL 和 pre-β1-HDL:与动脉粥样保护的相关性。
J Lipid Res. 2011 Dec;52(12):2304-2313. doi: 10.1194/jlr.P016816. Epub 2011 Sep 26.
9
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.高密度脂蛋白(HDL)的检测、颗粒异质性、建议的命名法,以及与动脉粥样硬化性心血管事件的关系。
Clin Chem. 2011 Mar;57(3):392-410. doi: 10.1373/clinchem.2010.155333. Epub 2011 Jan 25.
10
Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.凝胶过滤色谱法分离的人血浆高密度脂蛋白的蛋白质组学特征。
J Proteome Res. 2010 Oct 1;9(10):5239-49. doi: 10.1021/pr100520x.